Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
An Intraoperative Guidance Platform for Radio Frequency Ablation
- Status
- COMPLETED
- Phase
- NA
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Personalized DC Vaccine for Postoperative Cancer
- Status
- RECRUITING
- Phase
- PHASE1
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
- Status
- UNKNOWN
- Phase
- PHASE1
TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1